30 June 2015
Advanced Accelerator Applications S.A., an international specialist in Molecular Nuclear Medicine (MNM) and member of Atlanpole Biotherapies, announce s that it has entered into a distribution agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD (“FRI”), a leading in – country distributor of nuclear medicine and diagnostic imaging products. Lutathera is currently in a pivotal Phase III trial, both in the US and EU, with results expected in Q3.